Arimiplex 1 mg (100 Tabs)

Axiolabs Arimiplex

Arimiplex contains Anastrozole, a potent non-steroidal aromatase inhibitor widely used in bodybuilding and performance environments to manage estrogen levels during anabolic steroid cycles. Proper estrogen control helps reduce unwanted effects such as water retention, gynecomastia risk, and hormonal imbalance.

DRUG COMPOSITION

Each tablet contains 1 mg of Anastrozole as the active ingredient, combined with pharmaceutical-grade excipients for accurate dosing and consistency.

PHARMACEUTICAL FORM

Oral tablets supplied in sealed sachet packaging to maintain stability and protect against environmental exposure.

PHARMACEUTICAL GROUP AND ATC CODE

Aromatase inhibitors. ATC Code: L02BG03.

PHARMACOLOGICAL PROPERTIES

Anastrozole works by inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogen. By lowering circulating estrogen levels, Arimiplex supports a drier, leaner physique and improved hormonal control during testosterone or estrogen-aromatizing cycles.

THERAPEUTICAL INDICATIONS

Medically, Anastrozole is used in hormone-responsive conditions. In performance settings, it is commonly utilized to manage estrogen-related side effects during anabolic steroid use.

DOSES AND METHOD OF ADMINISTRATION

Typical performance-based dosing ranges from 0.25 mg to 1 mg taken every other day, depending on compound selection, dosage, and individual estrogen sensitivity. Tablets are taken orally.

CYCLE / STACKING

Arimiplex is most commonly stacked alongside aromatizing anabolic steroids to maintain estrogen balance. Common cycle support combinations include:

• Testaplex E 250 to control estrogen conversion during testosterone cycles
• Sustaplex 350 for blended testosterone protocols requiring consistent estrogen management
• Decaplex 250 where estrogen control may help reduce water retention

POST CYCLE THERAPY

Anastrozole is sometimes used selectively during post-cycle phases, depending on estrogen rebound risk. PCT strategies should be tailored carefully to avoid excessive estrogen suppression.

SIDE EFFECTS

Possible side effects include joint dryness, reduced libido, fatigue, and mood changes. Excessive estrogen suppression increases the likelihood of adverse effects.

CONTRAINDICATIONS

Not recommended for individuals with known hypersensitivity to Anastrozole or those with pre-existing conditions affected by estrogen suppression.

OVERDOSE

Overuse may result in excessively low estrogen levels, potentially leading to joint discomfort, hormonal imbalance, and decreased overall well-being.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE

Estrogen is essential for joint, cardiovascular, and neurological health. Arimiplex should be used conservatively and adjusted based on individual response.

INTERACTIONS WITH OTHER DRUGS

Concurrent use with other estrogen-lowering agents may amplify suppression effects. Monitoring is advised when combining multiple hormonal compounds.

PRESENTATION, PACKAGING

100 oral tablets containing 1 mg Anastrozole each, packaged in sachets.

STORAGE

Store in a cool, dry place away from heat, light, and moisture.

DELIVERY TO THE USA

Discreet and secure shipping available throughout the United States with reliable delivery times.

LEGAL STATUS

Prescription medication in many regions. Offered for research and informational purposes where applicable.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Axiolabs Pharmaceuticals

EXTERNAL LINKS

• Anastrozole: MedlinePlus Drug Information

PROFILE

• Chemical name: Anastrozole
• Chemical formula: C17H19N5
• Percentage of anabolic activity: 0%
• Percentage of androgenic activity: 0%
• Active half life: ~48 hours
• Recommended dosage: 0.25–1 mg EOD (cycle dependent)
• Acne: No
• Bloating (water retention): No
• HBR: No
• Hepatic toxicity: Low
• Aromatization: No

Third Party Lab Test

2026-03-23

View Result

1.09 mg